Hepatocellular carcinoma in hepatectomized patients: Biologic and therapeutic implications

被引:1
|
作者
Makatsoris, T
Petsas, T
Tsamandas, AC
Pagoni, N
Papathanassiou, Z
Karavis, D
Karatza, C
Kardamakis, D
Kalofonos, H
机构
[1] Univ Patras, Sch Med, Dept Internal Med, GR-26110 Patras, Greece
[2] Univ Patras, Sch Med, Div Oncol, GR-26110 Patras, Greece
[3] Univ Patras, Sch Med, Dept Radiol, GR-26110 Patras, Greece
[4] Univ Patras, Sch Med, Div Pathol, GR-26110 Patras, Greece
[5] Univ Patras, Sch Med, Div Surg, GR-26110 Patras, Greece
关键词
hepatocellular carcinoma; hepatectomy; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The macroscopic and microscopic features of 60 hepatocellular carcinomas (HCC) were investigated and correlated with patients' disease-free survival Patients and Methods: The study included 60 HCCs removed, by partial hepatectomy, from an equal number of patients. In these tumors, several macroscopic and microscopic features were assessed, graded and correlated with disease-free survival. Results: HCCs begin as small, well differentiated tumors that have an increased proliferation rate and neovascularization. Vascular invasion, which is the strongest predictor of disease recurrence, correlated significant with tumor number and size, the predominant and worst degree of differentiation, and the apoptosis/mitosis ratio. In the absence of macroscopic or large vessel invasion, the largest tumor size (p=0.006), apoptosislmitosis ratio (p=0.03) and number of tumors (p=0.04) were independent predictors of disease-free survival. Conclusion: This study showed that, in humans, the prognosis of HCC depends on several biological factors. Aggressive biological behavior (vascular invasion and recurrence) correlated significantly with: a) alterations in the apoptosislinitosis ratio and b) architectural and cellular alterations.
引用
收藏
页码:3067 / 3073
页数:7
相关论文
共 50 条
  • [41] Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
    Borel, Florie
    Konstantinova, Pavlina
    Jansen, Peter L. M.
    JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1371 - 1383
  • [42] Tamibarotene: a new hope for therapeutic efficacy in hepatocellular carcinoma patients
    Fu, Junliang
    Zhang, Ji-Yuan
    Wang, Fu-Sheng
    HEPATOLOGY INTERNATIONAL, 2014, 8 (01) : 1 - 3
  • [43] Tamibarotene: a new hope for therapeutic efficacy in hepatocellular carcinoma patients
    Junliang Fu
    Ji-Yuan Zhang
    Fu-Sheng Wang
    Hepatology International, 2014, 8 : 1 - 3
  • [44] CURRENT BIOLOGIC AND THERAPEUTIC IMPLICATIONS IN THE SURGERY OF NEUROBLASTOMA
    AZIZKHAN, RG
    HAASE, GM
    SEMINARS IN SURGICAL ONCOLOGY, 1993, 9 (06): : 493 - 501
  • [45] Interturnorat angiogenic heterogeneity: biologic and therapeutic implications
    Hasina, R
    Whipple, M
    Kuo, WP
    Tetriakova, M
    Ohno-Machado, L
    Lingen, MW
    LUNG CANCER, 2004, 46 : S72 - S72
  • [46] Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension
    Maesaka, Kazuki
    Sakamori, Ryotaro
    Yamada, Ryoko
    Urabe, Ayako
    Tahata, Yuki
    Oshita, Masahide
    Ohkawa, Kazuyoshi
    Mita, Eiji
    Hagiwara, Hideki
    Tamura, Shinji
    Ito, Toshifumi
    Yakushijin, Takayuki
    Iio, Sadaharu
    Kodama, Takahiro
    Hikita, Hayato
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY RESEARCH, 2020, 50 (09) : 1091 - 1100
  • [47] The Impact of Inflammation on the Therapeutic Outcome of SBRT in Patients with hepatocellular Carcinoma
    Radicioni, G.
    Exner, J. -P.
    Adebahr, S.
    Haehl, E.
    Spohn, S.
    Ruehle, A.
    Zamboglou, C.
    Sprave, T.
    Nicolay, N. H.
    Grosu, A. -L.
    Gkika, E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S43 - S44
  • [48] JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications
    Rah, Bilal
    Farhat, Nada Mazen
    Hamad, Mawieh
    Muhammad, Jibran Sualeh
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3147 - 3157
  • [49] JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications
    Bilal Rah
    Nada Mazen Farhat
    Mawieh Hamad
    Jibran Sualeh Muhammad
    Clinical and Experimental Medicine, 2023, 23 : 3147 - 3157
  • [50] GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications
    Du, Yi-Ning
    Zhao, Jin-Wei
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1171 - 1183